
Sign up to save your podcasts
Or


🫀 NEWTON-CABG Trial: Can intensive LDL-C lowering prevent vein graft failure after CABG?
💉 Evolocumab slashed LDL-C by ~50%, but did not improve SVG patency at 2 years. Why? Timing is everything.
🧠Early SVG failure = thrombosis & hyperplasia—not classic atherosclerosis. LDL-C ≠magic bullet here.
#Cardiology #CABG #LDL #PCSK9 #Evolocumab #CardioTrials #Lipids #HeartHealth #GraftPatency #ClinicalResearch #JACC #TheLancet #SurgeryMeetsPrevention
By Dr RR Baliga, MD, MBA5
66 ratings
🫀 NEWTON-CABG Trial: Can intensive LDL-C lowering prevent vein graft failure after CABG?
💉 Evolocumab slashed LDL-C by ~50%, but did not improve SVG patency at 2 years. Why? Timing is everything.
🧠Early SVG failure = thrombosis & hyperplasia—not classic atherosclerosis. LDL-C ≠magic bullet here.
#Cardiology #CABG #LDL #PCSK9 #Evolocumab #CardioTrials #Lipids #HeartHealth #GraftPatency #ClinicalResearch #JACC #TheLancet #SurgeryMeetsPrevention

902 Listeners

3,375 Listeners

21,240 Listeners